Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones

Elena Denisenko, Leanne de Kock, Adeline Tan, Aaron B Beasley, Maria Beilin, Matthew E Jones, Rui Hou, Dáithí Ó Muirí, Sanela Bilic, G Raj K A Mohan, Stuart Salfinger, Simon Fox, Khaing P W Hmon, Yen Yeow, Youngmi Kim, Rhea John, Tami S Gilderman, Emily Killingbeck, Elin S Gray, Paul A CohenYu Yu, Alistair R R Forrest

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Abstract

High-grade serous ovarian carcinoma (HGSOC) is genetically unstable and characterised by the presence of subclones with distinct genotypes. Intratumoural heterogeneity is linked to recurrence, chemotherapy resistance, and poor prognosis. Here, we use spatial transcriptomics to identify HGSOC subclones and study their association with infiltrating cell populations. Visium spatial transcriptomics reveals multiple tumour subclones with different copy number alterations present within individual tumour sections. These subclones differentially express various ligands and receptors and are predicted to differentially associate with different stromal and immune cell populations. In one sample, CosMx single molecule imaging reveals subclones differentially associating with immune cell populations, fibroblasts, and endothelial cells. Cell-to-cell communication analysis identifies subclone-specific signalling to stromal and immune cells and multiple subclone-specific autocrine loops. Our study highlights the high degree of subclonal heterogeneity in HGSOC and suggests that subclone-specific ligand and receptor expression patterns likely modulate how HGSOC cells interact with their local microenvironment.

Original languageEnglish
Article number2860
JournalNature Communications
Volume15
Issue number1
Early online date3 Apr 2024
DOIs
Publication statusPublished - Dec 2024

Fingerprint

Dive into the research topics of 'Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones'. Together they form a unique fingerprint.

Cite this